Clinical Study
Immunoreactivity of the 14F7 Mab (Raised against N-Glycolyl GM3 Ganglioside) as a Positive Prognostic Factor in Non-Small-Cell Lung Cancer
Table 3
Correlation between pathological features and 14F7 Mab immunorecognition in non-small-cell lung carcinoma.
| Pathological features | 14F7 Mab reactivity | No. | Intensity of reaction | % of positive cells | value | value |
| Gender | 28 | 0.1723 | 0.1152 | Age | 28 | 0.8443 | 0.6818 | Tumor size | 28 | 0.7052 | 0.8801 | Tumor stage | 28 | 0.3797 | 0.0760 | Type of carcinoma | 28 | 0.7786 | 0.9090 | Grade of differentiation | 28 | 0.3155 | 0.3192 | Degree of pleomorphism | 28 | 0.0713 | 0.0001 | Necrotic index | 28 | 0.2021 | 0.1804 |
|
|
No. Number of cases, % percentages, value using Spearman correlation test.
|